ESC 365 - Rebuttal - PRO.

Open Access

Rebuttal - PRO.

Session: Controversies in ablation therapy: asymptomatic atrial fibrillation and atrial fibrillation in heart failure

Topic: Atrial fibrillation (AF)

Event: EHRA EUROPACE - CARDIOSTIM 2017

Congress Session

7 more presentations in this session

Patients with paroxysmal atrial fibrillation should undergo ablation, even if asymptomatic, to prevent stroke and life-long anticoagulation - PRO.

Speaker: Doctor D. Packer (Rochester, US)

Patients with paroxysmal atrial fibrillation should undergo ablation, even if asymptomatic, to prevent stroke and life-long anticoagulation - CONTRA.

Speaker: Professor F. Braunschweig (Stockholm, SE)

Rebuttal - CONTRA.

Ablation of atrial fibrillation should be used frequently in heart failure - PRO.

Speaker: Professor L. Di Biase (The Bronx, US)

Atrial fibrillation ablation is rarely needed in heart failure - CONTRA.

Speaker: Professor F. Ruschitzka (Zurich, CH)

Access the full session

Controversies in ablation therapy: asymptomatic atrial fibrillation and atrial fibrillation in heart failure

Speakers: Doctor D. Packer, Professor F. Braunschweig, Professor L. Di Biase, Professor F. Ruschitzka

About the event

EHRA EUROPACE - CARDIOSTIM 2017

18 June - 21 June 2017

Sessions Presentations

Congress

This platform is supported by